New eye drop takes on vuity in Pupil-Size showdown

NCT ID NCT06783686

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This early-phase study tested whether a new eye drop called NV701 works better than the existing drop Vuity for shrinking pupil size in people with presbyopia (age-related blurry near vision). Fifty-five adults aged 40-55 received one dose of each drop in different eyes. Researchers measured pupil size over 8 hours to see which drop caused more constriction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Pilocarpine 1.25% eye drops

What this could lead to

If NV701 works better than Vuity, it could offer a more effective option for temporarily improving near vision in people with presbyopia.

What could go wrong

This is a very early, small study (55 people) testing only a single dose. It may not show a meaningful difference, and results may not apply to long-term use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRESBYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Miosis presbyopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arizona Eye Center

    Chandler, Arizona, 85224, United States

  • Global Research Management, Inc

    Glendale, California, 91204, United States